Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer ; volume:29 ; number:1 ; day:27 ; month:3 ; year:2024 ; pages:1-19 ; date:12.2024
European journal of medical research ; 29, Heft 1 (27.3.2024), 1-19, 12.2024
- Creator
-
Lin, Kaili
Wang, Yongfeng
Liu, Fangyu
You, Taifu
Liu, Xiongxiong
Liu, Runzhang
Li, Zeyang
Zhen, Chunyu
Zhang, Yunxia
Liu, Xingguang
Cai, Hui
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40001-024-01766-y
- URN
-
urn:nbn:de:101:1-2406130844330.447676623668
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, Kaili
- Wang, Yongfeng
- Liu, Fangyu
- You, Taifu
- Liu, Xiongxiong
- Liu, Runzhang
- Li, Zeyang
- Zhen, Chunyu
- Zhang, Yunxia
- Liu, Xingguang
- Cai, Hui
- SpringerLink (Online service)
Other Objects (12)
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
Pan-cancer analysis of the prognostic and immunological role of PAQR4
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
The prognostic value and immunological role of CD44 in pan-cancer study
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
Pan-cancer analysis of the prognostic and immunological role of PAQR4
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
The prognostic value and immunological role of CD44 in pan-cancer study
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
Pan-cancer analysis of the prognostic and immunological role of PAQR4
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
The prognostic value and immunological role of CD44 in pan-cancer study
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer